A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension

Study Identifier
CN-BRI-1002
CT.gov Identifier
NCT02003534
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Glaucoma - Open Angle
  • Ocular Hypertension
    • Study Drug
  • 0.15% Brimonidine Tartrate
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    N/A
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosis of open-angle glaucoma or ocular hypertension
    Exclusion Criteria:
    * Used Alphagan® in previous 3 months

    Protocol Summary

    This study will evaluate 0.15% brimonidine tartrate in patients with primary open angle glaucoma and ocular hypertension.

    Study Locations

    Location
    Status
    Location
    Shanghai, China
    Status
    Not applicable